Septerna announces collaboration with Novo Nordisk has become effective - 8-K ($11.40, 0.00)
Street Takeaways - GLP-1 Rx Tracker for week ended June 20th
StreetAccount Summary - Trading higher/lower: EU mid-morning
FTC grants antitrust clearance for Novo Nordisk's collaboration with Septerna (DKK 433.05, -2.20)
Powered by FactSet Research Systems Inc.